- Home
- AGEN vs JRSH Comparison
AGEN vs JRSH Comparison
Compare AGEN & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- JRSH
- Stock Information
- Founded
- AGEN 1994
- JRSH 2016
- Country
- AGEN United States
- JRSH United States
- Employees
- AGEN N/A
- JRSH N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- JRSH Apparel
- Sector
- AGEN Health Care
- JRSH Consumer Discretionary
- Exchange
- AGEN Nasdaq
- JRSH Nasdaq
- Market Cap
- AGEN 38.1M
- JRSH 44.5M
- IPO Year
- AGEN 2000
- JRSH 2018
- Fundamental
- Price
- AGEN $2.96
- JRSH $2.99
- Analyst Decision
- AGEN Buy
- JRSH
- Analyst Count
- AGEN 4
- JRSH 0
- Target Price
- AGEN $8.00
- JRSH N/A
- AVG Volume (30 Days)
- AGEN 655.0K
- JRSH 17.7K
- Earning Date
- AGEN 05-06-2025
- JRSH 02-11-2025
- Dividend Yield
- AGEN N/A
- JRSH 6.87%
- EPS Growth
- AGEN N/A
- JRSH N/A
- EPS
- AGEN N/A
- JRSH N/A
- Revenue
- AGEN $103,463,000.00
- JRSH $138,135,034.00
- Revenue This Year
- AGEN $4.03
- JRSH $29.89
- Revenue Next Year
- AGEN $5.57
- JRSH $8.30
- P/E Ratio
- AGEN N/A
- JRSH N/A
- Revenue Growth
- AGEN N/A
- JRSH 15.70
- 52 Week Low
- AGEN $1.38
- JRSH $2.68
- 52 Week High
- AGEN $19.69
- JRSH $4.17
- Technical
- Relative Strength Index (RSI)
- AGEN 78.44
- JRSH 39.34
- Support Level
- AGEN $1.60
- JRSH $2.85
- Resistance Level
- AGEN $1.83
- JRSH $3.02
- Average True Range (ATR)
- AGEN 0.31
- JRSH 0.14
- MACD
- AGEN 0.21
- JRSH 0.00
- Stochastic Oscillator
- AGEN 97.52
- JRSH 38.30
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.